Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
Htike ZZ, Zaccardi F, Papamargaritis D, Webb DR, Khunti K, Davies MJ
By The Numbers Total Revenue: $71.7 billion ($67.2 billion in Q2 2025) Net Income: $1.66 billion ($1.53 billion in Q2 2025) Earnings Per Share: Adjusted after-tax income of $7.78 ($7.20 in Q2 2025) Share Repurchases: $250 million in Q2 2026 Dividend Declared: $1.56 per share in Q2 2026 Stock Price Movement: Shares dropped 2% to $290.20 Thursday afternoon
Theyll send someone to go home with you
The BMJ , 392 , e085304
Fat Reduction Injection Quick Facts Sculpted jawline Reduce cellulite Permanent results Non-surgical procedure Todays Best Option for Fat Dissolving Injections Kybella Kybella Injections Kybella is an FDA approved injectable treatment designed to target small, specific pockets of fat such as a double chin caused by submental fat
